• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

    1.456 -0.029 (-1.96%)
    Streaming Delayed Price Updated: 10:37 AM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Enveric Biosciences, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    News headline image
    Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More ↗
    New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian... 
    Via Benzinga
    News headline image
    Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More ↗
    Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD 
    Via Benzinga
    News headline image
    30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond ↗
    The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health... 
    Via Benzinga
    News headline image
    Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More ↗
    Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury 
    Via Benzinga
    News headline image
    Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
    From Enveric Biosciences
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
    Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. 
    Via Benzinga
    News headline image
    Enveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-Market
    From Enveric Biosciences
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More ↗
    President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also... 
    Via Benzinga
    News headline image
    Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373
    From Enveric Biosciences
    Via Business Wire
    News headline image
    5 Biotech stocks tapping into unmet mental health treatment needs
    Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments. 
    Via MarketBeat
    News headline image
    Enveric Biosciences to Participate in Biotech Showcase 2024 During “J.P. Morgan Week 2024”
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More ↗
    Biden To Decide On Psychedelic Therapy Bill 
    Via Benzinga
    News headline image
    Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More ↗
    John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy 
    Via Benzinga
    News headline image
    Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More ↗
    Defense Dept. Funds Ketamine Study For PTSD Treatment  
    Via Benzinga
    News headline image
    Enveric Biosciences Selects Development Candidates from EVM301 Series Based on Potential to Minimize or Eliminate the Hallucinogenic Effect of Psychedelic-Derived Compounds
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Enveric Biosciences Announces Manuscript Describing the Development of Lead Product Candidate, EB-373, to be Featured on the Cover of the Journal of Medicinal Chemistry
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More ↗
    GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan 
    Via Benzinga
    Topics Cannabis
    News headline image
    Enveric Biosciences Announces Presentation of Two Posters at Canadian Chemical Engineering Conference (CSChE 2023)
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials ↗
    Enveric Biosciences (NASDAQ: ENVB), a biopharma company developing novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, reported its... 
    Via Benzinga
    News headline image
    Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results
    From Enveric Biosciences, Inc.
    Via Business Wire
    News headline image
    Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More ↗
    Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans? 
    Via Benzinga
    Topics Initial Public Offering
    News headline image
    Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More ↗
    DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court 
    Via Benzinga
    Topics Economy
    News headline image
    Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More ↗
    Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted 
    Via Benzinga
    Topics Intellectual Property
    News headline image
    Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted ↗
    Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts 
    Via Benzinga
    News headline image
    Enveric Biosciences to Present at the Centurion One 5th Global Summit
    From Enveric Biosciences
    Via Business Wire
    News headline image
    Enveric Biosciences Initiates GLP Toxicology & Safety Pharmacology Studies for Lead Candidate EB-373, a Next Generation Psilocin Prodrug Targeting Psychiatric Disorders
    From Enveric Biosciences
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.